Brief: Goldman Sachs Group's Long Position In Kindstar Globalgene Technology Rises To 5.43%- HKEX Filing
July 23 (Reuters) - Hong Kong stock exchange filing:
* GOLDMAN SACHS GROUP INC BOUGHT 4.06 MLN SHARES IN KINDSTAR
GLOBALGENE TECHNOLOGY 9960.HK AT AVG PRICE OF HK$8.55 ($1.10)
PER SHARE ON JULY 19 - HKEX FILING
* GOLDMAN SACHS GROUP INC'S LONG POSITION IN KINDSTAR
GLOBALGENE
TECHNOLOGY RISES TO 5.43% FROM 4.98% - HKEX FILING
Source text in English: https://bit.ly/3y2SFEF
Further company coverage: 9960.HK
($1 = 7.7692 Hong Kong dollars)
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on Kindstar Globalgene Technology
See all newsChina's Kindstar Globalgene H1 loss narrows after oncology testing expansion
Brief: Kindstar Globalgene Technology Posts Full-Year Loss Attributable Of RMB58.7 Million
Brief: Kindstar Globalgene Technology Inc Unit To Buy 40% Of Huaxi Kindstar
Brief: Kindstar Globalgene Technology Expects HY Net Loss Of RMB30-35 Million
Brief: Kindstar Globalgene Technology Sees FY Loss Between RMB55 Million And RMB65 Million